{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:26:03Z","timestamp":1764433563637},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatic infarction is a rare liver condition. The purpose of this study is to report a case of hepatic infarction caused by thrombus formation following portal vein stent implantation in a patient with hepatocellular carcinoma and portal vein tumor thrombus, and to explore the underlying causes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case report<\/jats:title>\n                <jats:p>The patient in this study was a 52-year-old male admitted with diffuse hepatocellular carcinoma involving the right lobe and portal vein tumor thrombus. After undergoing portal vein stent implantation and <jats:sup>125<\/jats:sup>I particle strand implantation treatment, the portal vein was patent, and the pressure decreased. However, multiple instances of hepatic artery chemoembolization combined with targeted immunotherapy resulted in gradual reduction in the diameter of the hepatic artery and affecting hepatic arterial blood flow. Two months post-stent implantation, thrombus formation within the stent was noted, and the patient\u2019s condition did not improve with anticoagulant therapy, as evidenced by follow-up CT scans showing an increase in thrombi. Six months later, the patient suffered from gastrointestinal bleeding and, despite emergency esophagogastric variceal ligation and hemostatic treatment, developed hepatic parenchymal infarction and liver function failure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We reveal the underlying cause is that (1) thrombus formation within the portal vein stent, leading to portal vein embolism and obstructed blood flow due to exacerbate portal hypertension after various treatments; and (2) the effect of hepatic artery chemoembolization, immunotherapy, and targeted therapy on tumor angiogenesis, causing reduced hepatic artery diameter and impaired arterial blood flow. These factors disrupt the liver\u2019s dual blood supply system, ultimately contributing to hepatic infarction. To our knowledge, this is the first report of hepatic infarction as a complication following portal vein stent implantation for hepatocellular carcinoma with portal vein tumor thrombus, and it holds significant reference value for guiding the treatment of hepatocellular carcinoma with concurrent portal vein tumor thrombus in a clinical setting.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-024-05826-y","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T09:02:14Z","timestamp":1718614934000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatic infarction occurred after 125I particle stent treatment for hepatocellular carcinoma with portal vein tumor thrombus: A case report"],"prefix":"10.1007","volume":"150","author":[{"given":"Jiemin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"issue":"10","key":"5826_CR1","doi-asserted-by":"publisher","first-page":"865","DOI":"10.4161\/cbt.12.10.17676","volume":"12","author":"L Chuan-Xing","year":"2011","unstructured":"Chuan-Xing L, Xu H, Bao-Shan H et al (2011) Efficacy of therapy for hepatocellular carcinoma with portal vein tumor thrombus: chemoembolization and stent combined with iodine-125 seed. Cancer Biol Ther 12(10):865\u2013871","journal-title":"Cancer Biol Ther"},{"issue":"13","key":"5826_CR2","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.2364","volume":"7","author":"F Du","year":"2017","unstructured":"Du F, Zhao X, Fan D (2017) Tumorigenicity Assay in Nude Mice. Bio Protoc. 7(13):e2364","journal-title":"Bio Protoc."},{"issue":"1112","key":"5826_CR3","doi-asserted-by":"publisher","first-page":"20190279","DOI":"10.1259\/bjr.20190279","volume":"93","author":"S Li","year":"2020","unstructured":"Li S, Li L, Li B et al (2020a) Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis. Br J Radiol 93(1112):20190279","journal-title":"Br J Radiol"},{"key":"5826_CR4","first-page":"4109216","volume":"2020","author":"Z Li","year":"2020","unstructured":"Li Z, Si G, Jiao DC et al (2020b) Portal vein stenting combined with 125I particle chain implantation followed by As2O3 in the treatment of hepatocellular carcinoma with portal vein tumour thrombus. Biomed Res Int 2020:4109216","journal-title":"Biomed Res Int"},{"issue":"6","key":"5826_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jvir.2014.11.041","volume":"26","author":"JE Lopera","year":"2015","unstructured":"Lopera JE, Katabathina V, Bosworth B et al (2015) Segmental liver ischemia\/infarction after elective transjugular intrahepatic portosystemic shunt creation: clinical outcomes in 10 patients. J Vasc Interv Radiol 26(6):835\u2013841","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"5826_CR6","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jvir.2017.02.014","volume":"28","author":"J Lu","year":"2017","unstructured":"Lu J, Guo JH, Zhu HD et al (2017) Safety and efficacy of irradiation stent placement for malignant portal vein thrombus combined with transarterial chemoembolization for hepatocellular carcinoma: a single-center experience. J Vasc Interv Radiol 28(6):786-794.e3","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"5826_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12072-015-9663-8","volume":"10","author":"JJ Luo","year":"2016","unstructured":"Luo JJ, Zhang ZH, Liu QX et al (2016) Endovascular brachytherapy combined with stent placement and TACE for treatment of HCC with main portal vein tumor thrombus. Hepatol Int 10(1):185\u2013195","journal-title":"Hepatol Int"},{"issue":"5","key":"5826_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1034\/j.1600-0676.2001.210510.x","volume":"21","author":"H Mayan","year":"2001","unstructured":"Mayan H, Kantor R, Rimon U et al (2001) Fatal liver infarction after transjugular intrahepatic portosystemic shunt procedure. Liver 21(5):361\u2013364","journal-title":"Liver"},{"issue":"5","key":"5826_CR9","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1600-0676.1993.tb00638.x","volume":"13","author":"M Saegusa","year":"1993","unstructured":"Saegusa M, Takano Y, Okudaira M (1993) Human hepatic infarction: histopathological and postmortem angiological studies. Liver 13(5):239\u2013245","journal-title":"Liver"},{"issue":"2","key":"5826_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/jhep.2000.9603","volume":"32","author":"E Villa","year":"2000","unstructured":"Villa E, Moles A, Ferretti I et al (2000) Natural history of inoperable hepatocellular carcinoma: estrogen receptors\u2019 status in the tumor is the strongest prognostic factor for survival. Hepatology 32(2):233\u2013238","journal-title":"Hepatology"},{"issue":"7","key":"5826_CR11","doi-asserted-by":"publisher","first-page":"12108","DOI":"10.18632\/oncotarget.14520","volume":"8","author":"TZ Yu","year":"2017","unstructured":"Yu TZ, Zhang W, Liu QX et al (2017) Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus. Oncotarget 8(7):12108\u201312119","journal-title":"Oncotarget"},{"issue":"4","key":"5826_CR12","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.brachy.2019.01.014","volume":"18","author":"D Yuan","year":"2019","unstructured":"Yuan D, Gao Z, Zhao J et al (2019) 125I seed implantation for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis. Brachytherapy 18(4):521\u2013529","journal-title":"Brachytherapy"},{"issue":"3","key":"5826_CR13","first-page":"587","volume":"6","author":"W Zhang","year":"2016","unstructured":"Zhang W, Luo J, Liu Q et al (2016) Brachytherapy with Iodine-125 seeds strand for treatment of main portal vein tumor thrombi: an experimental study in a rabbit model. Am J Cancer Res 6(3):587\u2013599","journal-title":"Am J Cancer Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05826-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05826-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05826-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T10:53:57Z","timestamp":1720522437000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05826-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":13,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["5826"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05826-y","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]},"assertion":[{"value":"7 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The patient provided informed consent to publish their case details and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Details of the case reported in the article were approved by the central institution, Affiliated Hospital of Guilin Medical College.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"308"}}